M&A

Axogen agrees to acquire BioCircuit for $200M (announced September 2026)

Axogen entered into a definitive agreement to acquire BioCircuit for $200 million (Axogen PR / 8-K, 10 September 2026). The transaction had not closed as of the note date; close was expected in Q4 2026.

More top stories

2d ago

Mercedes-Benz bets $560M on AI to cut car development by 17 months
2d ago

Partners Group cuts dozens of buyout jobs, raises $510M for credit push
3h ago

Elroy Air CEO details Chaparral drone ahead of $961M SPAC merger